» Articles » PMID: 19479038

Mice Deficient in Ribosomal Protein S6 Phosphorylation Suffer from Muscle Weakness That Reflects a Growth Defect and Energy Deficit

Overview
Journal PLoS One
Date 2009 May 30
PMID 19479038
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mice, whose ribosomal protein S6 cannot be phosphorylated due to replacement of all five phosphorylatable serine residues by alanines (rpS6(P-/-)), are viable and fertile. However, phenotypic characterization of these mice and embryo fibroblasts derived from them, has established the role of these modifications in the regulation of the size of several cell types, as well as pancreatic beta-cell function and glucose homeostasis. A relatively passive behavior of these mice has raised the possibility that they suffer from muscle weakness, which has, indeed, been confirmed by a variety of physical performance tests.

Methodology/principal Findings: A large variety of experimental methodologies, including morphometric measurements of histological preparations, high throughput proteomic analysis, positron emission tomography (PET) and numerous biochemical assays, were used in an attempt to establish the mechanism underlying the relative weakness of rpS6(P-/-) muscles. Collectively, these experiments have demonstrated that the physical inferiority appears to result from two defects: a) a decrease in total muscle mass that reflects impaired growth, rather than aberrant differentiation of myofibers, as well as a diminished abundance of contractile proteins; and b) a reduced content of ATP and phosphocreatine, two readily available energy sources. The abundance of three mitochondrial proteins has been shown to diminish in the knockin mouse. However, the apparent energy deficiency in this genotype does not result from a lower mitochondrial mass or compromised activity of enzymes of the oxidative phosphorylation, nor does it reflect a decline in insulin-dependent glucose uptake, or diminution in storage of glycogen or triacylglycerol (TG) in the muscle.

Conclusions/significance: This study establishes rpS6 phosphorylation as a determinant of muscle strength through its role in regulation of myofiber growth and energy content. Interestingly, a similar role has been assigned for ribosomal protein S6 kinase 1, even though it regulates myoblast growth in an rpS6 phosphorylation-independent fashion.

Citing Articles

Delivery of a Jagged1-PEG-MAL hydrogel with pediatric human bone cells regenerates critically sized craniofacial bone defects.

Kamalakar A, Tobin B, Kaimari S, Robinson M, Toma A, Cha T Elife. 2024; 13.

PMID: 39401071 PMC: 11473100. DOI: 10.7554/eLife.92925.


Investigating the Regulation of Ribosomal Protein S6 Kinase 1 by CoAlation.

Malanchuk O, Bdzhola A, Palchevskyi S, Bdzhola V, Chai P, Pardo O Int J Mol Sci. 2024; 25(16).

PMID: 39201434 PMC: 11354579. DOI: 10.3390/ijms25168747.


A phosphorylation-deficient ribosomal protein eS6 is largely functional in , rescuing mutant defects from global translation and gene expression to photosynthesis and growth.

Dasgupta A, Urquidi Camacho R, Enganti R, Cho S, Tucker L, Torreverde J Plant Direct. 2024; 8(1):e566.

PMID: 38250458 PMC: 10799217. DOI: 10.1002/pld3.566.


Delivery of A Jagged1-PEG-MAL hydrogel with Pediatric Human Bone Cells Regenerates Critically-Sized Craniofacial Bone Defects.

Kamalakar A, Tobin B, Kaimari S, Robinson M, Toma A, Cha T bioRxiv. 2023; .

PMID: 37873448 PMC: 10592619. DOI: 10.1101/2023.10.06.561291.


Impact of ergot alkaloid and steroidal implant on whole-body protein turnover and expression of mTOR pathway proteins in muscle of cattle.

Ferguson T, Loos C, Vanzant E, Urschel K, Klotz J, McLeod K Front Vet Sci. 2023; 10:1104361.

PMID: 37143501 PMC: 10151678. DOI: 10.3389/fvets.2023.1104361.


References
1.
Ohanna M, Sobering A, Lapointe T, Lorenzo L, Praud C, Petroulakis E . Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol. 2005; 7(3):286-94. DOI: 10.1038/ncb1231. View

2.
Watchko J, Daood M, Labella J . Creatine kinase activity in rat skeletal muscle relates to myosin phenotype during development. Pediatr Res. 1996; 40(1):53-8. DOI: 10.1203/00006450-199607000-00010. View

3.
Fingar D, Salama S, Tsou C, Harlow E, Blenis J . Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 2002; 16(12):1472-87. PMC: 186342. DOI: 10.1101/gad.995802. View

4.
Meyuhas O . Physiological roles of ribosomal protein S6: one of its kind. Int Rev Cell Mol Biol. 2008; 268:1-37. DOI: 10.1016/S1937-6448(08)00801-0. View

5.
Gressner A, Wool I . The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated. J Biol Chem. 1974; 249(21):6917-25. View